| Literature DB >> 26384280 |
Abstract
In this issue of Blood, Donadieu et al present what may be the most encouraging data to date on a group of patients with Langerhans cell histiocytosis (LCH), which historically has poor disease-free survival and poor overall survival.Entities:
Mesh：
Substances：
Year: 2015 PMID： 26384280 DOI： 10.1182/blood-2015-08-661496
Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113